Health
Drug combination could make curative surgery possible for some liver cancer patients – News-Medical.net
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible…
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Results published July 29 in the journal…
Continue Reading
-
General18 hours agoVictorian school teacher charged with soliciting child abuse material
-
General9 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business21 hours agoEconomic roundtable or maturity test?
-
General23 hours agoBackpackers threaten to leave town if Broome’s ‘bush doof’ crackdown continues